Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use
Launched by UNIVERSITY OF RIJEKA · Mar 19, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The study objectives are to:
1. assess QoL in subjects using psycholeptics and psychoanaleptics,
2. analyze identified DRPs and their causes in subjects using psycholeptics and psychoanaleptics
3. evaluate the correlation between the type and total number of DRPs identified in a single subject with QoL,
4. describe the impact of pharmacists´ intervention in the identification and resolution of the DRPs and their causes on subjects´ QoL.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult participants (years 18+)
- • Usage of psycholeptic or psychoanaleptic medicines
- • Residence in Istrian County (Croatia)
- Exclusion Criteria:
- • Minor participants
- • Hospitalization during study participation
- • Unable to live by themselves
- • Unable to participate in study for 3 months
About University Of Rijeka
The University of Rijeka, a prominent academic institution in Croatia, is dedicated to advancing medical research and clinical studies through its various faculties and research centers. With a strong emphasis on innovation and collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering scientific advancements. Leveraging its multidisciplinary approach, the University of Rijeka is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pula, , Croatia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
